Motorika is developing robotic rehabilitation solutions for patients suffering from a variety of neurological and orthopedic conditions, including stroke, traumatic brain injury, and spinal cord injury.
With more than 30 patents filed to date, Motorikas two signature robotic rehabilitation platforms the clinically proven ReoGo for upper limb therapy and the Optimal-G Pro for gait rehabilitation have assisted in more than 1 million patient therapy sessions in hundreds of clinics and hospitals worldwide.
Motorikas systems harness the patients own capacity to retrain the brain using principles of neuroplasticity, repetitive motion, and biofeedback, all of which are guided and mediated by the patient-specific functionality of the machines.
Through personally designed repetitive motions, patients are able to effectively rewire their brains neural pathways and synapses to improve their range and speed of motion, accuracy and smoothness of movement, muscle strength, cognitive functions, and normal gait patterns.
Motorikas products are commercially available in 33 countries worldwide, including in Europe, the U.S., and China.
Motorika is a portfolio company of Hobart Group.